Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Capital Work in Progress

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹306 Cr₹207 Cr₹493 Cr₹670 Cr₹372 Cr

What is the latest Capital Work in Progress ratio of MANKIND PHARMA ?

The latest Capital Work in Progress ratio of MANKIND PHARMA is ₹306 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹306 Cr
Mar2024₹207 Cr
Mar2023₹493 Cr
Mar2022₹670 Cr
Mar2021₹372 Cr

How is Capital Work in Progress of MANKIND PHARMA Trending?

Years Capital Work in Progress % Change
Mar2025 ₹306 Cr
47.82
Mar2024 ₹207 Cr
-58.01
Mar2023 ₹493 Cr
-26.38
Mar2022 ₹670 Cr
80.26
Mar2021 ₹372 Cr -

Compare Capital Work in Progress of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹89,742.7 Cr 1.5% -2.8% -19.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,708.0 Cr -2.9% -1.8% -2.5% Stock Analytics
DIVIS LABORATORIES ₹171,975.0 Cr 2.1% 0.2% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,619.0 Cr 0.5% 2.2% 11.2% Stock Analytics
CIPLA ₹122,539.0 Cr 0.7% -0.8% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,741.0 Cr -0.1% 2.5% 2.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.5%

-2.8%

-19.5%

SENSEX

-0.4%

-0.3%

3.9%


You may also like the below Video Courses